Recombinant HI_0872 is a full-length protein (1–471 amino acids) expressed in Escherichia coli with an N-terminal His tag for purification . Key specifications include:
HI_0872 is annotated as an uncharacterized sugar transferase, likely utilizing nucleotide sugar donors (e.g., UDP-glucose) to modify substrates . Glycosyltransferases in Haemophilus influenzae are implicated in processes such as:
Surface protein glycosylation (e.g., HMW1 adhesin, critical for epithelial cell adherence) .
Lipopolysaccharide (LPS) biosynthesis, influencing pathogenicity and immune evasion .
This recombinant protein is utilized in:
Enzymatic assays to study sugar transfer mechanisms.
Structural studies via X-ray crystallography or cryo-EM.
Antibody production for detecting native HI_0872 in bacterial samples.
While HI_0872 remains uncharacterized, related glycosyltransferases in Haemophilus influenzae exhibit:
Key research gaps include:
KEGG: hin:HI0872
STRING: 71421.HI0872
HI_0872 is an uncharacterized sugar transferase from Haemophilus influenzae with a predicted function in lipopolysaccharide (LPS) biosynthesis. It belongs to a locus containing several LPS-related genes identified through genome sequence analysis . The protein has 471 amino acids and is thought to participate in the transfer of sugar moieties during the assembly of bacterial cell surface structures.
The gene encoding HI_0872 is part of a genomic region with a distinctly lower G+C content (approximately 30%) compared to the H. influenzae genome average of 38.2%, suggesting possible acquisition through horizontal gene transfer . While its precise biochemical function remains to be fully characterized, its homology and genomic context suggest involvement in cell surface glycosylation pathways that may contribute to bacterial virulence and host interaction mechanisms.
Recombinant HI_0872 is commonly expressed as a His-tagged fusion protein in Escherichia coli expression systems. The typical methodology involves:
Expression Vector Selection: Vectors containing an N-terminal His-tag (usually 6× or 9× histidine) are preferred for efficient purification .
Host Cell Optimization: E. coli strains optimized for membrane or difficult protein expression are recommended, as HI_0872 contains transmembrane domains that can complicate expression .
Induction Conditions: Expression is typically induced with IPTG at reduced temperatures (16-25°C) to improve protein folding.
Purification Protocol:
Storage Formulation: Purified protein is typically stored in Tris/PBS-based buffer with 6-50% trehalose or glycerol at pH 8.0 to maintain stability .
The resulting protein preparations typically achieve >90% purity as determined by SDS-PAGE analysis .
HI_0872 belongs to a family of bacterial sugar transferases but remains relatively uncharacterized compared to well-studied homologs. Key comparative findings include:
Unlike many well-characterized sugar transferases such as those in the AsTG1 system from oats that have defined roles in biosynthetic pathways , HI_0872 remains functionally enigmatic. The protein shows some sequence similarity to enzymes involved in O-antigen biosynthesis, suggesting a potential role in cell surface glycoconjugate assembly.
When designing experiments with recombinant HI_0872, appropriate controls are essential to ensure valid interpretation of results:
Recommended Experimental Controls:
Expression Controls:
Purification Controls:
Non-induced culture sample (background protein control)
Sequential elution fractions to track purification efficiency
Size exclusion chromatography to assess protein aggregation state
Activity Assay Controls:
Heat-inactivated HI_0872 (negative enzymatic control)
Known glycosyltransferase with similar predicted function (positive control)
Substrate-only and enzyme-only reactions (background reaction controls)
Testing with multiple potential sugar donors (UDP-glucose, UDP-galactose, etc.)
Stability Controls:
Specificity Controls:
Related but distinct sugar transferases to establish specificity
Mutated substrate analogs to determine binding requirements
Competition assays with predicted similar substrates
Proper implementation of these controls helps distinguish genuine enzymatic activity from artifacts and establishes a reliable experimental framework for characterizing this uncharacterized protein.
Determining the substrate specificity of uncharacterized sugar transferases like HI_0872 requires a multi-faceted approach combining biochemical, analytical, and structural methods:
In vitro Glycosyltransferase Assays:
Radiometric Assays: Using radiolabeled nucleotide-sugar donors (typically UDP-[14C]glucose or UDP-[3H]glucose) to detect transfer to potential acceptors
Colorimetric/Fluorometric Assays: Employing coupled enzyme systems that detect released UDP
HPLC-MS Analysis: Monitoring substrate conversion and product formation through analytical separation and mass detection, similar to approaches used for AsUGT91G16
Substrate Library Screening:
Testing arrays of potential acceptor molecules including:
LPS core fragments
Synthetic oligosaccharides
Fluorescently-labeled glycan acceptors
Examining various nucleotide-sugar donors (UDP-glucose, UDP-galactose, etc.)
Transglycosylation Activity Assessment:
Heterologous Expression Systems:
Structural Biology Approaches:
Co-crystallization with substrate analogs
Molecular docking simulations
Site-directed mutagenesis of predicted catalytic residues
Each approach has strengths and limitations, and researchers should employ multiple complementary methods to build a comprehensive understanding of HI_0872 substrate specificity.
The role of HI_0872 in H. influenzae pathogenesis likely involves modulation of cell surface structures that interact with host defenses, though direct evidence remains limited:
LPS Modification and Host Immune Evasion:
Biofilm Formation:
Antibiotic Resistance:
Host Colonization:
Relation to Vaccine Development:
The high-throughput insertion tracking by deep sequencing (HITS) methodology has been employed to identify genes essential for H. influenzae survival in infection models . Application of this approach to studying HI_0872 could provide direct evidence of its role in pathogenesis.
Systematic gene knockout and complementation studies represent powerful approaches for elucidating HI_0872 function:
Recommended Methodology:
Precise Gene Deletion:
Construction of markerless, in-frame deletion mutants using homologous recombination
Creation of conditional mutants if HI_0872 is potentially essential
Development of complementation constructs with native and epitope-tagged versions
Phenotypic Characterization:
Comprehensive LPS Analysis:
Silver staining of LPS preparations
Mass spectrometry characterization of LPS structures
Immunoblotting with monoclonal antibodies against specific LPS epitopes
Growth and Stress Response:
Growth curves under various conditions
Sensitivity to antimicrobial peptides, detergents, and antibiotics
Survival under oxidative and pH stress
Host Interaction Studies:
Adhesion and invasion assays with relevant cell lines
Biofilm formation capacity
Serum resistance testing
Animal Infection Models:
High-Throughput Methods:
Complementation Analysis:
Trans-complementation: Reintroduction of HI_0872 at a neutral site
Cis-complementation: Restoration of the gene in its native locus
Heterologous complementation: Testing whether sugar transferases from other species can restore function
These approaches should be integrated with biochemical characterization to establish definitive links between enzymatic activity and biological function.
Several structural biology approaches offer promising avenues for characterizing HI_0872, each with specific advantages:
The optimal approach would likely combine computational modeling with targeted experimental validation, followed by high-resolution structural determination once expression and purification conditions are optimized.
Development of high-throughput screening (HTS) approaches for HI_0872 inhibitors requires careful assay design and validation:
Primary Assay Development:
Fluorescence-Based Assays:
UDP-Glo™ assay to detect released UDP from sugar-nucleotide donors
FRET-based assays using labeled acceptor substrates
Fluorescently labeled substrate analogs
Colorimetric Assays:
Malachite green assay for phosphate release (coupled assay)
Tetrazolium-based redox assays for coupled enzyme reactions
Assay Optimization and Validation:
Determination of optimal enzyme concentration and reaction time
DMSO tolerance testing
Statistical validation: Z' factor >0.5 for robustness
Positive controls: Known glycosyltransferase inhibitors as benchmark
Compound Library Selection:
Focused libraries targeting sugar-nucleotide binding pockets
Natural product libraries (bacterial secondary metabolites)
Fragment-based approaches for initial hits
Virtual screening pre-filtering
Counter-screening and Selectivity:
Testing against related sugar transferases
Mammalian glycosyltransferase counter-screens
Cell toxicity assessment
Hit Validation and Characterization:
Dose-response relationships
Mechanism of inhibition studies
Binding affinity determination (ITC, SPR)
Structural studies of enzyme-inhibitor complexes
Cell-Based Secondary Assays:
Impact on H. influenzae growth
Effects on LPS structure
Biofilm formation inhibition
Potentiation of antibiotic activity
In Silico Support:
Molecular docking of hits
Structure-activity relationship analysis
Pharmacophore modeling for hit expansion
This systematic approach would enable identification of HI_0872 inhibitors that could serve as both chemical probes to study enzyme function and potential starting points for antimicrobial development.
The evolutionary context of HI_0872 provides insights into its biological significance and potential functions:
Genomic Context and Horizontal Gene Transfer:
Phylogenetic Distribution:
Analysis of HI_0872 homologs across bacterial species reveals:
Core presence in H. influenzae strains
Variable distribution in related Pasteurellaceae
Distant homologs in other gram-negative pathogens
This pattern suggests specialized functions potentially related to niche adaptation
Selective Pressures:
Cell surface modifications often evolve under selective pressure from:
Host immune systems
Bacteriophage predation
Competition with other microorganisms
The maintenance of HI_0872 in H. influenzae genomes suggests functional importance
Structural Adaptation:
Comparative analysis with characterized sugar transferases can reveal:
Conserved catalytic residues indicating enzymatic mechanism
Variable regions potentially involved in substrate specificity
Structural adaptations for membrane association
Role in Phase Variation:
Many surface-modifying enzymes in H. influenzae are subject to phase variation
This mechanism creates phenotypic diversity within bacterial populations
Phase variation in LPS structure contributes to immune evasion and adaptation to changing environments
Impact of Vaccination:
Evolutionary analysis of HI_0872 offers valuable context for understanding its biological role and potential significance in bacterial adaptation and pathogenesis.
Understanding the expression patterns of HI_0872 during infection requires specialized approaches that can detect gene and protein expression in complex host environments:
Transcriptomic Approaches:
RNA-Seq from Infection Models:
Direct RNA extraction from infected tissues
Dual RNA-Seq to simultaneously profile host and pathogen
Enrichment methods for bacterial transcripts
qRT-PCR with Specific Primers:
Targeted approach for specific time points
Requires careful normalization with reference genes
Can be applied to samples with limited bacterial RNA
In vivo Expression Technology (IVET):
Promoter trap approach to identify genes expressed during infection
Selection for promoters active in vivo but not in vitro
Protein-Level Detection:
Custom Antibodies Against HI_0872:
Western blotting from infection samples
Immunohistochemistry on tissue sections
Flow cytometry of recovered bacteria
Tagged Protein Approaches:
Chromosomal integration of epitope-tagged HI_0872
Luciferase or fluorescent protein reporters
FRET-based biosensors for protein activity
Single-Cell Approaches:
Single-Cell RNA-Seq:
Captures expression heterogeneity in bacterial populations
Can identify subpopulations with distinct expression profiles
Fluorescent Reporters with Microscopy:
Direct visualization of expression in tissue context
Time-lapse imaging for dynamic expression patterns
Systems Biology Integration:
Multi-omics Integration:
Correlation of transcriptomics, proteomics, and metabolomics data
Network analysis of co-expressed genes
Computational Modeling:
Prediction of expression based on regulatory networks
Machine learning approaches to identify expression patterns
High-Throughput Mutation Analysis:
These methodologies can be applied across different infection models, time points, and conditions to build a comprehensive picture of HI_0872 expression patterns and regulation during infection.
Ensuring consistent quality of recombinant HI_0872 preparations is essential for reliable experimental results. Key quality control parameters include:
Additional specialized assessments may include:
Functional Activity:
Development of a specific activity assay once substrates are identified
Comparison to reference standard across batches
Thermal Stability:
Differential scanning fluorimetry (DSF)
Determination of melting temperature (Tm)
Post-Translational Modifications:
Phosphorylation status
Glycosylation analysis if applicable
Buffer Compatibility:
Testing stability in various buffer conditions
Determination of optimal pH and ionic strength
Implementing these quality control measures ensures that experimental variations are due to biological phenomena rather than inconsistencies in protein preparation.
The predicted membrane association of HI_0872 presents specific challenges for expression, purification, and functional characterization. Effective strategies include:
Expression Optimization:
Specialized E. coli Strains:
C41(DE3) or C43(DE3) designed for membrane protein expression
Tuner™ strains for control of expression level
Strains with enhanced membrane capacity
Expression Constructs:
Testing N-terminal vs. C-terminal tags
Creation of truncated constructs without transmembrane regions
Fusion partners that enhance solubility (MBP, SUMO)
Induction Conditions:
Low IPTG concentrations (0.1-0.5 mM)
Reduced temperature (16-20°C)
Extended expression periods (24-48 hours)
Membrane Protein Extraction:
Detergent Screening:
Mild detergents (DDM, LMNG, OG)
Native membrane mimetics (nanodiscs, SMALPs)
Systematic screening of detergent combinations
Solubilization Conditions:
Optimization of pH, salt concentration
Addition of glycerol or stabilizing agents
Detergent concentration gradient testing
Alternative Expression Systems:
Cell-Free Expression:
Direct incorporation into liposomes or nanodiscs
Control over membrane-mimetic environment
Eukaryotic Expression:
Yeast (Pichia pastoris)
Insect cells (Sf9, High Five™)
Mammalian cells for complex post-translational modifications
Functional Characterization:
Reconstitution Systems:
Proteoliposomes
Supported lipid bilayers
Droplet interface bilayers
Surface Plasmon Resonance (SPR):
Capture on sensor chips via His-tag
Direct analysis of substrate interactions
Structural Approaches:
Crystallization Strategies:
Lipidic cubic phase (LCP) crystallization
Co-crystallization with antibody fragments
Detergent screening matrix
Cryo-EM:
Analysis in detergent micelles or nanodiscs
2D crystallization in lipid bilayers
By systematically addressing these challenges, researchers can overcome the difficulties associated with membrane proteins and establish reliable systems for studying HI_0872.
Detecting sugar transferase activity in complex biological samples requires sensitive and specific analytical techniques:
Activity-Based Protein Profiling (ABPP):
Development of activity-based probes for glycosyltransferases
Click chemistry approaches for probe attachment
Enrichment and identification of active enzymes
Metabolic Labeling:
Incorporation of azide or alkyne-modified sugar precursors
Bioorthogonal conjugation for visualization or enrichment
Mass spectrometry analysis of labeled glycoconjugates
Mass Spectrometry-Based Methods:
Multiple Reaction Monitoring (MRM):
Targeted analysis of specific glycoconjugates
High sensitivity and specificity
Absolute quantification with internal standards
Untargeted Glycomics:
Comprehensive analysis of glycan structures
Comparison between wild-type and mutant samples
Integration with proteomics data
Immunological Methods:
Glycan-Specific Antibodies:
Development of antibodies against specific glycan structures
ELISA or Western blot detection
Immunofluorescence microscopy
Lectin-Based Detection:
Panels of lectins with defined specificities
Microarray formats for high-throughput analysis
Flow cytometry for cell surface analysis
Chromatographic Methods:
HPLC with Multiple Detection Methods:
UV detection for proteins
Fluorescence for labeled glycans
Mass spectrometry for structure identification
Capillary Electrophoresis:
High-resolution separation of complex mixtures
Minimal sample requirements
Compatible with various detection methods
Enzymatic Activity Assays:
Coupled Enzyme Assays:
Detection of UDP release through auxiliary enzymes
Continuous monitoring of activity
Adaptable to high-throughput formats
Radiometric Assays:
Transfer of radiolabeled sugars
High sensitivity but lower throughput
Requires special handling and disposal
These approaches can be combined and adapted to specific experimental contexts, enabling detection of sugar transferase activity even in complex biological matrices such as bacterial lysates, infected tissues, or clinical samples.
Distinguishing between the functions of HI_0872 and other LPS-related genes requires careful experimental design and multiple complementary approaches:
Combinatorial Genetics:
Single and Multiple Gene Deletions:
Creation of a panel of single gene knockouts
Construction of double and triple mutants
Systematic phenotypic analysis
Complementation Studies:
Cross-complementation between related genes
Domain swapping experiments
Heterologous expression of orthologous genes
Biochemical Characterization:
Substrate Specificity Profiling:
Comparison of substrate utilization patterns
Competition assays with shared substrates
Kinetic parameters (Km, Vmax, kcat)
Enzyme Mechanism Studies:
Determination of reaction stereochemistry
Identification of catalytic residues
Inhibitor sensitivity patterns
Structural Analysis of LPS:
Mass Spectrometry:
High-resolution MS/MS analysis
Comparative glycomics between mutants
Isotope labeling to track specific modifications
NMR Spectroscopy:
Detailed structural characterization
Assignment of linkage types and anomeric configurations
Comparison between wild-type and mutant structures
Temporal Expression Analysis:
Time-Course Studies:
Determination of expression patterns during growth
Analysis of expression during infection
Response to environmental stimuli
Regulatory Studies:
Identification of transcription factors
Characterization of promoter elements
Epigenetic regulation mechanisms
Protein-Protein Interaction Studies:
Co-Immunoprecipitation:
Identification of interaction partners
Assembly of enzyme complexes
Co-localization studies
Bacterial Two-Hybrid Screens:
Systematic analysis of protein interactions
Identification of functional complexes
Mapping of interaction domains
Functional Genomics Approaches:
Synthetic Genetic Arrays:
Identification of genetic interactions
Pathway mapping through epistasis analysis
Suppressor screens
Transposon Sequencing:
Identification of genes with related functions
Synthetic lethal interactions
Conditional essentiality
By integrating these approaches, researchers can develop a comprehensive understanding of the specific roles of HI_0872 in relation to other LPS-related genes, revealing both unique functions and potential redundancies or synergies.
Understanding HI_0872 could inform several antimicrobial development strategies targeting H. influenzae and potentially other gram-negative pathogens:
Direct Enzymatic Inhibition:
Development of specific HI_0872 inhibitors that disrupt LPS biosynthesis
Design of transition state analogs based on the enzymatic mechanism
Structure-based drug design once protein structure is resolved
Antivirulence Approaches:
Targeting surface structures without direct bactericidal effects
Attenuation of pathogenicity rather than growth inhibition
Potentially lower selective pressure for resistance development
Vaccine Development:
Sensitization Strategies:
LPS modifications often contribute to antimicrobial resistance
Inhibitors of HI_0872 might sensitize bacteria to existing antibiotics
Combination therapy approaches targeting cell envelope biogenesis
Diagnostic Applications:
Host-Targeted Approaches:
Blocking host receptors that interact with bacterial glycoconjugates
Modulation of host glycosyltransferases that may interact with bacterial structures
Enhancement of innate immune recognition of modified surface structures
The increasing prevalence of non-typeable H. influenzae infections in the post-Hib vaccine era and the emergence of antimicrobial resistance underscore the importance of novel therapeutic approaches targeting surface structure biosynthesis.
Studying glycosyltransferase mechanisms in membrane-associated enzymes like HI_0872 requires specialized techniques that can accommodate the membrane environment:
Advanced Spectroscopic Methods:
Site-Directed Spin Labeling with EPR:
Introduction of nitroxide spin labels at specific positions
Analysis of local dynamics and conformational changes
Compatible with membrane environments
Solid-State NMR:
Analysis of proteins in native-like membrane environments
Determination of structure and dynamics
Observation of substrate interactions
Time-Resolved Fluorescence:
FRET-based approaches to track domain movements
Analysis of enzyme-substrate interactions
Determination of reaction kinetics
Single-Molecule Techniques:
Atomic Force Microscopy (AFM):
Direct visualization of membrane-embedded proteins
Force measurements of substrate binding
Observation of conformational changes
Single-Molecule FRET:
Detection of conformational changes during catalysis
Identification of rare or transient states
Analysis of reaction pathways
Native Mass Spectrometry:
Nanodiscs with Mass Spectrometry:
Analysis of intact membrane protein complexes
Detection of non-covalent interactions
Observation of substrate binding
Hydrogen-Deuterium Exchange MS:
Mapping of solvent accessibility
Identification of conformational changes
Compatible with detergent-solubilized proteins
Cryo-EM Approaches:
Time-Resolved Cryo-EM:
Capturing catalytic intermediates
Visualization of enzyme-substrate complexes
Multiple conformational states
Electron Crystallography:
2D crystals in lipid bilayers
High-resolution structural determination
Native-like membrane environment
Computational Methods:
Molecular Dynamics Simulations:
Explicit membrane simulations
Free energy calculations for substrate binding
Reaction mechanism modeling
Quantum Mechanics/Molecular Mechanics (QM/MM):
Detailed analysis of reaction mechanisms
Energy profiles for catalytic steps
Electronic structure calculations
High-Throughput Mutagenesis:
Deep Mutational Scanning:
Comprehensive analysis of sequence-function relationships
Identification of catalytic residues
Mapping of substrate specificity determinants
These advanced techniques provide complementary information about enzyme mechanism and can overcome the challenges associated with studying membrane-associated glycosyltransferases.
Despite the available information, significant gaps remain in our understanding of HI_0872. Key limitations and approaches to address them include:
Functional Characterization:
Limitation: The precise enzymatic activity and substrates remain unknown
Approach: Systematic screening of potential sugar donors and acceptors using sensitive analytical methods like HPLC-MS
Challenge: Obtaining appropriate substrate candidates, especially if they are complex LPS intermediates
Structural Information:
Limitation: No high-resolution structure is available
Approach: Optimization of expression and purification for structural biology, potentially using truncated constructs
Challenge: Membrane association may complicate structural determination
In vivo Role:
Limitation: The contribution to bacterial physiology and pathogenesis is poorly defined
Approach: Generation of knockout mutants and comprehensive phenotypic characterization
Challenge: Potential functional redundancy with other glycosyltransferases
Expression and Regulation:
Limitation: Limited understanding of when and how HI_0872 is expressed
Approach: Transcriptomic and proteomic analysis under various conditions, including during infection
Challenge: Low expression levels or condition-specific expression
Evolutionary Context:
Limitation: Incomplete understanding of conservation and selection pressures
Approach: Comprehensive phylogenetic analysis across bacterial species with functional validation
Challenge: Annotation inconsistencies in bacterial genomes
Interaction Partners:
Limitation: Unknown protein-protein interactions that may be essential for function
Approach: Affinity purification coupled with mass spectrometry or bacterial two-hybrid screening
Challenge: Preserving transient or membrane-dependent interactions
Technical Limitations:
Limitation: Difficulty in expressing and purifying active enzyme
Approach: Exploration of alternative expression systems, including cell-free systems
Challenge: Maintaining native conformation and enzymatic activity
Translation to Therapeutic Applications:
Limitation: Unclear relevance as a therapeutic target
Approach: Validation studies in infection models with conditional mutants or specific inhibitors
Challenge: Demonstrating essentiality or significant contribution to virulence
Addressing these limitations requires a multidisciplinary approach combining biochemistry, structural biology, genetics, and infection biology to develop a comprehensive understanding of this uncharacterized sugar transferase.
Systems biology provides powerful frameworks for understanding HI_0872 within the broader context of bacterial physiology:
Multi-omics Integration:
Transcriptomics: RNA-Seq analysis of HI_0872 mutants to identify compensatory responses
Proteomics: Quantitative proteomics to detect changes in protein expression and post-translational modifications
Metabolomics: Analysis of metabolic changes, particularly in cell envelope components
Glycomics: Comprehensive analysis of glycan structures affected by HI_0872
Integration of these datasets to create a holistic view of HI_0872's impact
Network Analysis:
Protein-Protein Interaction Networks:
Identification of functional modules
Positioning of HI_0872 within cellular pathways
Detection of hub proteins and essential interactions
Gene Regulatory Networks:
Identification of transcription factors controlling HI_0872
Mapping of regulatory cascades
Feedback mechanisms and control circuits
Genome-Scale Modeling:
Flux Balance Analysis:
Integration of HI_0872 into genome-scale metabolic models
Prediction of metabolic consequences of gene deletion
Identification of synthetic lethal interactions
Whole-Cell Modeling:
Incorporation of LPS biosynthesis pathways
Prediction of phenotypic outcomes
Simulation of environmental perturbations
High-Throughput Phenotyping:
Phenotype Microarrays:
Testing growth under hundreds of conditions
Identification of condition-specific requirements
Comparative analysis of wild-type and mutant strains
Chemical Genomics:
Screening for compound-specific sensitivity
Identification of pathways linked to HI_0872 function
Drug-target interaction networks
Comparative Systems Biology:
Cross-Species Analysis:
Comparison with related enzymes in other bacteria
Evolutionary conservation of network properties
Identification of species-specific adaptations
Pan-Genome Analysis:
Distribution across H. influenzae isolates
Correlation with other genomic features
Association with specific pathotypes
In silico Prediction and Validation:
Hypothesis Generation:
Computational prediction of HI_0872 function
Simulation of system-wide effects
Prioritization of experimental validation
Model Refinement:
Iterative improvement based on experimental data
Integration of new knowledge
Development of predictive models
The HITS methodology previously applied to H. influenzae represents a systems-level approach that could be extended to study HI_0872 in various contexts, providing insights into its role within the broader bacterial physiological network.